LIGAND PHARMACEUTICALS INCORPORATED Notes Payable
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Notes Payable of $202.95 million as of 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:NotesPayable · last filed 2015-11-09
- 2015-09-30: Notes Payable $202.95M.
- 2015-06-30: Notes Payable $200.57M.
- 2015-03-31: Notes Payable $198.57M.
- 2014-12-31: Notes Payable $196.24M.
| Period end | Notes Payable |
|---|---|
| 2015-09-30 | $202.95M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $200.57M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $198.57M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $196.24M 10-Q · filed 2015-11-09 |
| 2014-09-30 | $193.97M 10-Q · filed 2014-10-31 |
| 2013-12-31 | $9.11M 10-Q · filed 2014-10-31 |